Wockhardt Quarterly Results for Trading Insights

WOCKPHARMA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹82 Cr
QSept 2025
Quarterly Results

Wockhardt Quarterly Results Key Highlights

  • Revenue of ₹803 Cr in Sept 2025 (+5.9% vs Mar 2025, -1.8% vs Sept 2024)
  • Net Profit of ₹82 Cr in Sept 2025 (+282.2% vs Mar 2025, +612.5% vs Sept 2024)
  • EBITDA of ₹199 Cr in Sept 2025 (+151.9% vs Mar 2025)
  • Operating Margin of 23.0% in Sept 2025 (+14.0pp vs Mar 2025)
  • Earnings Per Share of ₹4.81 in Sept 2025 (+406.4% vs Mar 2025)

Wockhardt Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 803 758 758 818 754 5.9% -1.8%
Net Profit (₹ Cr) 82 -45 -108 -16 -177 - -
EBITDA (₹ Cr) 199 79 -5 119 -49 - -
EPS (₹) 4.81 -1.57 -5.53 -1.47 -11.64 - -
Operating Margin (%) 23.0% 9.0% -3.0% 14.0% -15.0% - -

Wockhardt Share Price Trend Around Quarterly Results

Visualize Wockhardt's 1-year price movement across quarterly results — ideal for logging trades in Wockhardt share price chart using Tickjournal. All values in ₹.

Related Pages for Wockhardt

Additional stock information and data for WOCKPHARMA

WOCKPHARMA stock price chart
Wockhardt financial data
WOCKPHARMA market value
WOCKPHARMA FII DII holdings
WOCKPHARMA 52-week high low
Wockhardt P/B ratio trends
WOCKPHARMA fair value
WOCKPHARMA price trends

Profitability Ratios

Profit Margin 10.2%
EBITDA Margin 24.8%
Operating Margin 23.0%
ROE (Annual) 7.0%

Balance Sheet Highlights

Total Assets ₹8,135 Cr
Total Equity ₹4,657 Cr
Current Assets ₹2,465 Cr
Current Liabilities ₹1,436 Cr

Cash Flow Analysis

Operating Cash Flow ₹-22 Cr
Investing Cash Flow ₹-780 Cr
Financing Cash Flow ₹409 Cr
Net Cash Flow ₹-393 Cr

Current Market Data

Current Price ₹1465.70
Exchange NSE
Last Updated Jan 06, 2026

Revenue Trend (₹ Cr)

Sept 2024 818
Jun 2025 758
Mar 2025 758
Sept 2025 803

Net Profit Trend (₹ Cr)

Sept 2024 -16
Jun 2025 -108
Mar 2025 -45
Sept 2025 82

Operating Margin Trend (%)

Sept 2024 14.0%
Jun 2025 -3.0%
Mar 2025 9.0%
Sept 2025 23.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Wockhardt quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹412,613.60 Cr 1760.2 14,875 3,125 +10.8% - 21.0% 135.4
Divis Laboratories
Sept 2025 		₹169,700.80 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹129,171.09 Cr 3936.8 3,219 591 +11.3% - 18.4% 224.4
Cipla
Sept 2025 		₹121,238.47 Cr 1530.8 7,716 1,353 +12.0% - 17.5% 91.5
Dr Reddys Laborator…
Sept 2025 		₹104,570.84 Cr 1256.2 9,135 1,337 +1.1% - 14.6% 77.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores